Ignite Creation Date:
2025-12-24 @ 11:07 PM
Ignite Modification Date:
2026-01-03 @ 9:29 AM
Study NCT ID:
NCT03212469
Status:
COMPLETED
Last Update Posted:
2025-05-08
First Post:
2017-01-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Trial of Durvalumab and Tremelimumab in Combination With SBRT in Patients With Metastatic Cancer
Sponsor:
Gustave Roussy, Cancer Campus, Grand Paris